Vital.io guides 7M patients through ER, urgent care, inpatient & surgical visits, accurately predicting wait times, reassuring frustrated patients, and providing clear guidance on what to do next.

CLAYMONT, Del., Sept. 22, 2026 — Vital, which uses AI to predict ER wait times, explain doctors notes in human terms to hospitalized patients, and gives real-time updates during surgical procedures to family members, has been recognized by TIME and Statistica as a top company in the Health Information Management category. The award list was announced on September 17^th, 2026, and can be viewed on Time.com. Vital.io guides millions of patients during their visits, leading to lower leave-rate, fewer readmissions, better patient scores, and – unsurprisingly when you treat people right – better financial outcomes for 3 of the top 6 health systems, plus dozens of others.

“Wow! Happy to be recognized by TIME (and Statistica). And what a coincidence. Every morning, next to ‘Live, Laugh, Love’, I look at one of those TIME Person of the Year frames that’s really just a mirror. This award was clearly made to live beside it. I mean what do you do to hype yourself up to change healthcare each morning?” asks Aaron Patzer, Vital’s Cofounder & CEO. He further muses, “Seriously, by ‘you’ I mean you the human, the person who’s reading this press release. I’ve been worried that it’s all just AI agents these days. If you’ve made it this far, you’re going to love – okay, probably just tolerate – the rest. I wrote the whole thing, and quoted myself here, crazy right? Who’s regulating press releases, or more importantly, AI for that matter?”

Vital does a few things exceptionally well: it’s used by 65% of patients during hospital & emergency stays. Your standard comes-with-the-EHR software, 10-15% during a visit. As a result of being super-easy for patients, it produces great outcomes: 30-50% reduction in left-without-being-seen (LWBS) which is when patients are so fed up with waiting they bail; a 30% increase in follow-up visits, so people actually get better long term and don’t just end up back at the hospital. That’s our enterprise system.

Vital also runs Vital Care Finder (https://vit.al) directly for consumers. We have millions of doctors, dentists, nurses and physician assistants listed everywhere, sorted by price, which other find-a-doc systems seem to neglect. It matches using your clinical fingerprint, so the “best doctor” for you depends very much on what chronic conditions you have, age, language,s etc. It’s also built for AI, with deep integrations into ChatGPT & Claude via widgets and MCP servers.

We also are a founding member of AICareStandard.com created with industry leaders and executives from MedStar, IU Health, HCA, Patients for Patient Safety, Children’s Hospital Los Angeles and more.

In short, we’re the pro-patient company. And for all patients, rich and poor, insured or not. This feels rare in health care for some reason. We’re allowed to use like 1500 words, but press releases are a bit like corporate journal entries, self-focused and a bit look-at-me. Thanks for getting this far. Consider going outside. Or just standing up. Or drinking some water. Something for your health – we stopped short so you could.

About Vital.io

Vital.io today guides 7M patients annually through emergency, urgent care, and inpatient visits across dozens of health systems including 3 of the top 6 largest IDNs. Vital is known for its innovations in safe, patient-facing AI, including the doctor-to-patient translator launch in May 2023, and its status as a founding member of the PatientAI Collaborative™ at aicarestandard.com committed to safe, accurate, and clinically responsible AI-driven patient communication.

Vital was founded by Aaron Patzer, formerly Founder of Mint & VP of Product Innovation at Intuit, and Justin Schrager, MD, a practicing emergency physician at IU Health & Emory. Vital is backed by Transformation Capital, Threshold Ventures, First Round Capital, and luminaries in healthcare including the founders of Flat Iron Health, Patient Ping / Bamboo, and more.

Media Contact: Kathy English, [email protected]

SOURCE Vital Software Inc.

Founders will live and build together at a private camp in the Poconos, with mentors and speakers including Gary Vaynerchuk, Sophia Amoruso, Zach Yadegari and Brandon Bryant. The program will be filmed as a documentary series and closes with a Demo Day in front of investors.

NEW YORK, Sept. 22, 2026 — Stan, the company on a mission to help anyone live life on their own terms, today announced Launchpad, a 14-day program bringing 100 founders together to start and scale their companies by sharing their journey publicly. Participants will turn their ideas into companies, growing awareness around what they’re creating and learning how to build distribution from day one.

The program will run October 4–19th, 2026 at a private camp in the Poconos, about two hours from New York City, and will include masterclasses and mentorship from leading operators and investors, protected focus time, immunity and elimination rounds, and a closing Demo Day in front of actively investing firms.

Throughout the 14-day program, founders will live and learn alongside other early-stage entrepreneurs, receive ongoing mentorship from Stan co-founders Vitalii Dodonov and John Hu, and compete for a $100,000 prize. The full experience will be filmed and produced as a documentary competition series, giving audiences a front-row seat to the founder journey.

“Building is easy. Distribution is hard. You can build the best product in your category and still lose to someone who started building an audience a year earlier,” said Vitalii Dodonov, Co-Founder of Stan. “Building in public is how founders build distribution before they need it, and it’s what we will be teaching at Launchpad.”

Throughout the program, founders will use Stanley, a Personal Head of Content built by Stan, to document their journeys, develop content and share what they’re building with a broader audience, putting Stan’s belief that distribution is a core founder skill into practice.

Launchpad is open to early-stage software and AI founders, with roughly 30 teams made up of 100 founders expected to be selected. Programming will include sessions from Gary Vaynerchuk, serial entrepreneur, chairman of VaynerX and CEO of VaynerMedia; Zach Yadegari, co-founder of Cal AI and founder of Flow; Sophia Amoruso, founder and managing partner of Trust Fund and founder of Nasty Gal; and Brandon Bryant, co-founder and partner at Harlem Capital.

“A handful of people bet on me before there was anything to bet on. That is the only reason Stan exists,” said John Hu, Co-Founder of Stan. “Launchpad is our turn to make that bet on a hundred other founders.”

Applications are open now at launchpad.stan.com and will remain open until September 25th 2026.

About Stan
Stan is the ecosystem helping anyone live life on their own terms. Stan brings together Stanley, a personal Head of Content, and Stan Store, an all-in-one hub for selling digital products, coaching, and community programs. Since 2021, Stan has helped more than 90,000 people to build their visibility, their business and their confidence, earning more than $600M through Stan Store. We believe anyone, anywhere can make it if they work hard.

SOURCE Stan

Returning investors fund equity raise at $8.50 per share — more than 20% above the September 21 close

WILMINGTON, Del., Sept. 22, 2026 — Brand Engagement Network, Inc. (Nasdaq: BNAI) (“BEN” or the “Company”), an enterprise AI software company, today announced that it has entered into a securities purchase agreement for a $1,051,025 private placement of common stock priced at $8.50 per share. The purchase price represents more than a 20% premium to the Company’s September 21, 2026 closing price of $7.07.

The placement was subscribed in equal parts by returning investor BEN Capital Fund I, LLC and Joseph Bevash. The Company will issue an aggregate 123,650 shares of common stock. An initial $150,025 (17,650 shares) was funded at closing, with the remaining $901,000 to be funded in five equal monthly installments of $180,200 through February 5, 2027.

The transaction includes 100% warrant coverage. For each share purchased, the investors receive a six-month warrant to purchase one additional share at the same $8.50 exercise price. If the placement is fully funded, the warrants will cover up to 123,650 shares.

This transaction continues the clear 2026 trend of BEN securing equity commitments from sophisticated investors at significant premiums to the prevailing market. Prior private placements this year were priced at $63.25, $39.25, and $17.82, each above the then-current closing price, including placements priced 20% above the close.

“This is another above-market commitment from investors who already know the company — after Cataneo, after Accelevate, and while we continue to deploy enterprise AI,” said Tyler Luck, Chief Executive Officer of Brand Engagement Network. The people writing the checks are not trading the noise. They are funding the plan.”

Transaction Highlights

• $1,051,025 aggregate commitment at $8.50 per share
• More than 20% premium to the September 21, 2026 close of $7.07
• 123,650 shares, split equally between BEN Capital Fund I, LLC and Joseph Bevash
• $150,025 funded at initial closing; $901,000 to be funded over five months
• 1-for-1 six-month warrants at the same $8.50 strike price
• Continues a consistent 2026 track record of premium-priced private placements

The securities described in this release were offered and sold in private transactions pursuant to exemptions from the registration requirements of the Securities Act of 1933, as amended. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities.

About Brand Engagement Network

Brand Engagement Network, Inc. (Nasdaq: BNAI) builds secure, enterprise-grade artificial intelligence for the engagement layer of AI-where human intent is transformed into intelligent interactions, automated workflows, and real-world outcomes.  Powered by BEN’s proprietary Engagement Language Model (ELM), the technology enables conversational AI interactions that connect human intent to organizational data, workflows, and real-world outcomes. BEN’s AI operates within secure closed-loop environments using approved organizational data and built-in governance and compliance controls.  Trusted by organizations in regulated and high-impact industries, BEN helps bring AI into real operational settings where engagement drives outcomes and accountability matters. 

In June 2026, BEN acquired Cataneo GmbH, which provides enterprise software for advertising sales, scheduling, traffic, content management, monetization, analytics, CRM integration, and real-time reporting across linear, digital, and on-demand media. 

For more information, visit www.brandengagementnetwork.com

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws, including statements regarding the funding of remaining installments under the securities purchase agreement, issuance and exercise of warrants, use of proceeds, commercial execution, integration of acquired businesses, and future capital formation. Forward-looking statements are based on current expectations and are subject to risks and uncertainties that could cause actual results to differ materially, including the Purchasers’ performance of remaining funding obligations, Nasdaq listing and market conditions, dilution from the issuance of shares and warrant shares, the Company’s liquidity and going-concern considerations described in its SEC reports, integration of acquired businesses, and other risks described in the Company’s filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company undertakes no obligation to update any forward-looking statement except as required by law.

Contacts

Investor Relations
[email protected]

Media Relations
[email protected]

SOURCE Brand Engagement Network, Inc. (BEN)

Already used by more than 1 in 5 financial institutions to verify businesses and manage risk, Baselayer is extending its identity network to agents acting and transacting on their behalf

NEW YORK, Sept. 22, 2026 — Baselayer, the identity and risk infrastructure company trusted by 1 in 5 financial institutions nationwide, today announced it has raised a $35 million Series A led by M13, with participation from Torch Capital, Picus Ventures, Afore Capital, and Matt Thompson of Socure. Alongside the round, the company launched its Agentic Identity Suite, bringing the industry’s first interoperable trust layer and agentic fraud consortium to the global agentic economy.

The problem Baselayer solves

Agentic commerce is arriving faster than the trust infrastructure required to ensure it can safely flourish. In June, Stripe reported that 70% of the commands used to access data through its API now come from AI agents. Over the past year, Visa, Mastercard, and American Express have all shipped agent commerce protocols, and Shopify turned on agentic sales channels by default for roughly one million merchants.

That creates a new identity problem for financial infrastructure built to recognize people and businesses, not autonomous software acting on their behalf. Before a bank, merchant, or platform lets an agent transact, it has to know: who does this agent represent, is it authorized to act, and can it trust the party on the other side.

Baselayer already answers the equivalent questions for businesses. Its platform provides identity verification and risk infrastructure to 2,300+ financial institutions and payments companies, and has helped customers prevent more than $1 billion in fraud losses. Founded in 2024 by machine learning pioneer Timothy Hyde and risk management veteran Jonathan Awad, the company is now extending that same infrastructure to autonomous agents.

“Every era of commerce has required a new trust layer, but historically that infrastructure gets built only after fraud and abuse make the problem impossible to ignore,” said Jonathan Awad, co-founder and CEO of Baselayer. “Agentic commerce is moving too fast for the industry to repeat that mistake. We already help one in five U.S. financial institutions answer, ‘Can I trust this business?’ Now we’re building the infrastructure they need to answer, ‘Can I trust this agent, who does it represent, and what is it allowed to do?'”

The Agentic Identity Suite

Baselayer works with agent builders, card networks, and leading FIs and payments companies including FIS, Prove, Socure, Exa, Parallel Web Systems, Natural, Nevermined, Lane, and more, to offer agentic identity and risk solutions to meet accelerating enterprise demand.

Beyond the products they develop, Baselayer is helping to establish and promote the industry standards the agentic economy will run on, including the FIDO Alliance Authentication Working Group, Legal Context Protocol, and the x402 Identity Working Group alongside companies like Cloudflare, Google, Visa, and Mastercard.

“Agents don’t carry ID, and the infrastructure built to verify humans and businesses simply doesn’t recognize them,” said Timothy Hyde, co-founder and CTO of Baselayer. “Static fraud controls end up blocking good customers while sophisticated attacks walk through. We built the Agentic Identity Suite so any institution can know, cryptographically, which agent it’s dealing with, who that agent represents, and whether its own agent can safely proceed with any transaction.”

“AI agents are rapidly becoming economic actors, but the identity infrastructure underneath commerce was never designed for software that can open accounts, make purchases, move money, or enter into transactions on someone else’s behalf,” said Karl Alomar, Managing Partner at early stage venture capital firm M13. “That creates an enormous new trust problem, and we believe identity will become one of the foundational infrastructure layers of the agentic economy. What made Baselayer especially compelling is that Jonathan and Timothy are not starting from a whiteboard. They already have a network spanning more than 2,300 financial institutions, deep risk data, and infrastructure in production today. They have the distribution and the underlying trust graph to become the system institutions rely on to know not just who they are dealing with, but which agents are authorized to act for them.”

M13 manages $2.2 billion in assets and has backed 18 companies at seed or Series A that later reached unicorn status.

About Baselayer

Baselayer is the leading risk and identity infrastructure platform for 2,300+ financial institutions, Fortune 500s, and government agencies as they onboard and underwrite businesses, consumers, and the agents they deploy. Learn more at baselayer.com.

Media Contact

Jonathan Awad

Co-Founder & CEO, Baselayer

[email protected]

SOURCE Baselayer

Former financial leader at Radius Global Infrastructure and Crown Castle will steer finance strategy to meet next stage of enterprise, cloud and AI infrastructure demand

DALLAS, Sept. 22, 2026 — DataBank, a leading provider of enterprise-class colocation, interconnection, and managed services, announced today that Ben Lowe has been appointed Chief Financial Officer (CFO). Lowe will lead all of DataBank’s finance, accounting, treasury, and capital markets functions and will report to DataBank’s President and current CFO, Kevin Ooley, who will be transitioning to CEO on January 1, 2027. DataBank’s current CEO, Raul Martynek, will become Executive Chairman of the Board on January 1, 2027.

Lowe joins DataBank as the company embarks on its next phase of evolution, continuing to provide highly compliant, mission-critical, colocation services to 2,500+ enterprise customers while capitalizing on the rapid growth in digital infrastructure driven by AI and hyperscale cloud demand.  He brings to DataBank a deep reservoir of experience scaling financial operations and capital structures in both public and private equity-backed organizations as well as insight and perspective across the digital infrastructure ecosystem from data centers to wireless networks.  

“Ben possesses a mix of industry knowledge, financial acumen, and capital markets experience that will be incredibly valuable for DataBank as we enter this next chapter,” said Kevin Ooley, DataBank’s President and acting CFO. “His proven ability to access both public and private markets and his track-record of synthesizing capital with strategy will be critical as we navigate this next phase of evolution.”

Most recently, Lowe served as Chief Financial Officer at Radius Global Infrastructure, a portfolio company of EQT Active Core Infrastructure and the Public Sector Pension Investment Board that specializes in the strategic acquisition and management of critical telecommunication infrastructure including cell site leases, network switches/exchanges, fiber aggregation points, Distributed Antenna Systems (DAS), data centers, and towers.  Prior to that, Lowe served as Senior Vice President of Corporate Finance and Treasurer at Crown Castle, an owner and operator of approximately 40,000 wireless towers across the U.S.

“DataBank’s U.S. data center infrastructure footprint is unparalleled, and the company has a rich history of building long-term relationships with customers and capital markets alike,” said Lowe. “This is an incredible platform and track-record upon which to chart the next era of growth and I’m incredibly excited to be joining at such a monumental time.“

“I’m delighted to have Ben joining our leadership team,” added Raul Martynek, DataBank’s CEO. “He and Kevin are the right leaders to champion DataBank’s next phase of growth and continue our heritage of financial strength and performance. I look forward to supporting them in 2027 in my new role as Executive Chairman of the board.”

About DataBank

DataBank helps the world’s largest enterprises, technology, and content providers ensure their data and applications are always on, always secure, always compliant, and ready to scale to meet the needs of the artificial intelligence era.

Recognized by Deloitte in 2023 and 2024, and Inc. 5000 in 2024 as one of the fastest-growing private US companies, DataBank’s edge colocation and infrastructure footprint consists of 70+ “HPC-ready” data centers in 25+ markets, 20 interconnection hubs, and on-ramps to an ecosystem of cloud providers with virtually unlimited reach.

We combine these platforms with contract portability, managed security, compliance enablement, hands-on support, and a guarantee of 100% uptime availability, to give our customers absolute confidence in their IT infrastructure and the power to create a boundless digital future for their business.

To learn more, follow us on LinkedIn or subscribe to our YouTube channel. To tour a facility, visit DataBank or call 1(800) 840-7533.

SOURCE DataBank

Powered by agentic AI, Chamelio’s platform is primed to replace outdated legacy contract lifecycle management systems and empower legal teams to embrace AI-powered operations. Since its seed round five months ago, Chamelio’s ARR has grown 4x

NEW YORK, Sept. 22, 2026 — Chamelio, the AI-native platform for in-house legal teams, today announced a $26 million Series A round led by Entrée Capital, with participation from existing investors Work-Bench and Emerge Ventures. Bright Pixel Capital also participated. Chamelio boasts hundreds of customers, including Wiz, monday.com, Socure, AppsFlyer, and Wonderful.ai. The company will use the new funding to further develop its proprietary legal action model, grow its legal engineering and product teams and invest further in onboarding technology.

In-house legal departments are overworked and understaffed, with workload demands surging, while budgets and headcount are not keeping pace. An Association of Corporate Counsel survey from this year found that budget and resource constraints were a key barrier to success. Meanwhile, only 32% of legal departments expect to add attorney headcount this year, according to CLOC’s 2026 State of the Industry Report. Most in-house legal teams are still relying on legacy Contract Lifecycle Management (CLM) software built to store contracts, not analyze or act on them, with the painstaking additional work falling on the same number of overburdened teams.

The legal sector has adopted AI faster than almost any other profession. Deloitte predicts in three years, 30% of a legal team will be AI agents, and one in five will be hybrid lawyer-engineers. This role bridges the gap between technology and legal expertise. Chamelio enables the legal teams of today to delegate the tedious manual labor of contract review to autonomous agents, laying the groundwork for a completely different in-house composition of the future, consisting of both lawyers and AI agents.

Chamelio is an AI-native legal platform for in-house teams that manages and executes the full contract lifecycle, from drafting and negotiation to approvals, obligations, and ongoing legal workflows. Unlike traditional contract management systems built primarily to store documents and manage processes, Chamelio is trained on legal actions and can perform the work itself. It drafts from a company’s own contracts, reviews and negotiates terms, routes requests, manages obligations, and executes multistep legal workflows. Customers can deploy it autonomously for routine, low-risk work or keep a lawyer in the loop where oversight is needed. By handling routine tasks and decisions independently and escalating only the edge cases that require human judgment, Chamelio shifts the in-house lawyer’s role from labor-intensive execution to strategic oversight and judgment.

Chamelio also allows legal teams to easily build their own agents which support and interact with multiple functions across the organization, from procurement to finance, product to people, compliance to sales, helping scale and amplify legal capabilities for enterprise in the AI era.

“The mistake in legal AI has been assuming the future simply looks like today’s lawyer with faster contractual fact-checking,” said Alex Zilberman, CEO and co-founder of Chamelio. “AI in a legal setting shows dividends when it can make decisions intuitively, built on the corporate intelligence of each individual business. This is what Chamelio does. We ensure in-house legal departments deliver watertight contracts and outputs at AI speed, validated by the rigor of lawyers.”

“Chamelio is building the AI-native operating system for in-house legal teams – becoming the system of record, system of action, and system of intelligence for the modern legal function,” said Eran Bielski, General Partner at Entrée Capital. “What stood out to us was not only the strength of the product, but how quickly Chamelio’s founders execute, learn from customer feedback, and turn that feedback into a product with category-defining potential.”

Chamelio’s platform integrates with CRMs like Salesforce, as well as other tools such as Slack, NetSuite and procurement systems. Every deployment from Chamelio’s platform contains access to dedicated legal engineering expertise that helps customers migrate from legacy systems, structure their repositories, translate existing processes into workflows and get AI into production quickly.

Zilberman added: “Chamelio is empowering the next era of legal operations, one which includes vital human legal judgment, backed by legal engineers who turn that knowledge into systems and AI agents. With our platform underpinning every facet of in-house contract execution, we are redefining how in-house legal activities are carried out.”

About Chamelio

Founded in 2024 by serial entrepreneurs and two-time founders, Alex Zilberman and Gal Lellouche, alongside former general counsel, Gil Banyas, Chamelio is the AI system of action for in-house legal teams. Its platform combines contract negotiation, legal intake, workflows, contract intelligence and knowledge in one platform. Its software, AI-powered migration technology and legal engineering model helps corporate legal departments move from legacy systems to AI that does the work.

Media Contact

Headline Media
Jack Mendel – [email protected]

SOURCE Chamelio

Funding accelerates R&D and retail expansion as Bird&Be fills gaps in fertility care.

TORONTO, Sept. 22, 2026 — Bird&Be, the fertility and wellness brand making supplements and at-home tests for women and men at every stage of the fertility journey, today announced $13M in funding to fuel product development, retail expansion, and access to trusted, evidence-based reproductive health support – whether someone is trying to conceive, managing a condition like PMOS, supporting a pregnancy, or simply taking a proactive first step in understanding their fertility. The round is led by BDC Thrive, BFG Partners, and supported by BAM Ventures, Founder Collective, Rejuvenation Ventures, and HSR Ventures.

Why the fertility category needs a trusted intervention:

• 1 in 6 people experience infertility, and up to 50% of cases involve male factors; yet fewer than 1,400 fertility specialists (REIs) practice nationwide, and nearly half of U.S. counties lack an OB-GYN.
• PMOS affects 1 in 10 women but can take many years to diagnose, leaving an estimated 70% of women undiagnosed and unsupported in managing their cycles and fertility.
• Prenatal vitamins need a higher standard too: a recent Consumer Reports investigation found nearly all (15 of 17) prenatal vitamins tested contained more or less of key nutrients than their labels claimed, including folic acid, which is essential for neural tube development. Bird&Be’s Prenatal met all of its label claims in Consumer Reports’ evaluation. Note: Consumer Reports does not endorse products or services.

With third-party-tested supplements formulated and backed by OB-GYNS, REIs, and naturopathic fertility specialists, Bird&Be steps in to give women and men the nutritional support they need for healthy conception, pregnancies, and postpartum recovery. They are also the only brand to offer at-home diagnostic tests alongside supplements –  Sperm Test Kits and Ovarian Reserve Screening Tests for under $100 – giving couples the tools to take proactive care of their reproductive health to improve outcomes.

In its first three years, Bird&Be grew to an eight-figure brand with nearly 100% year-over-year growth and 75% of revenue coming from subscriptions. The brand has grown its clinician-referral channel 200% year-over-year — with more than 10% of customers now coming through a healthcare provider recommendation. Bird&Be launched in 300 Ulta Beauty stores in September 2025 and expanded to nearly 1,000 stores by spring 2026, becoming the first fertility brand to place male and female products side by side in a national beauty retailer. Bird&Be recently partnered with Mandell’s Clinical Pharmacy to extend its reach directly to patients navigating fertility treatment in all 50 states.

The new funding will fuel research and clinical studies, product development, continued retail expansion, and the growth of Bird&Be’s clinical distribution channel.

“We started Bird&Be because my Co-Founder Breanna Hughes and I didn’t have the support we needed navigating PMOS and pregnancy loss ourselves,” said Samantha Diamond, Bird&Be Co-Founder and CEO. “We get it because we lived it. Every product we make helps our customers and community feel educated and in control. We intentionally created a brand that would bring men into the fertility narrative as well, giving them the supplements and tools to care for their own reproductive health and grow their families. We’ve been able to support hundreds of thousands of people in their fertility journeys over the past few years and the new funding helps us make trusted products even more accessible when and where people need care most.”

“Bird&Be is building a category-defining company at the intersection of women’s health, consumer health, and preventative care,” said Mona Minhas, Managing Partner, BDC Thrive Venture Fund. “By combining science-backed products with accessible education, Bird&Be is addressing a significant unmet need in a large and underserved market. We’re excited to lead this investment and partner with the team as they scale their impact. Supporting exceptional women-led companies like Bird&Be is central to Thrive’s mandate and to BDC’s commitment to fueling innovation and economic growth in Canada.”

“Bird&Be pairs a deep body of fertility science with a product experience people actually stick with. That combination is rare,” said Elizabeth Earle, Vice President at BFG. “BFG strongly believes that brands built on real transparency, like Bird&Be, should be within reach of more people and we’re eager to support Samantha and Breanna’s mission in bringing them to women and men hoping to build their families.”

About Bird&Be

Bird&Be is a fertility and wellness brand providing supplements and at-home tests for both partners at every stage of the fertility journey. Formulated by fertility doctors, OB-GYNs, and naturopathic specialists, Bird&Be offers prenatal, pregnancy, postpartum, and hormone-supporting supplements with therapeutic, bioavailable, third-party-tested ingredients. Bird&Be products are available on birdandbe.com, in Ulta stores and online, and through clinical partnerships like Mandell’s Clinical Pharmacy. Learn more at birdandbe.com 

SOURCE Bird&Be

SAN DIEGO, Sept. 22, 2026 — Primrose Bio, Inc. (“Primrose”), a provider of production solutions for next-generation biologics, today announced the closing of a financing round led by new investor Signet Healthcare Partners (“Signet”), with significant participation from existing investors 1315 Capital, Ligand Pharmaceuticals Incorporated (Nasdaq: LGND), LDV Partners, and Agent Capital. In conjunction with the financing, James Gale, Founding Partner and Managing Director of Signet, has joined Primrose’s Board of Directors.

The proceeds will help Primrose continue to expand the reach and capabilities of its differentiated technology portfolio:

• Pfenex Expression Technology^® (“Pfenex”), a scalable microbial expression platform for efficient, high-yield production of complex, engineered proteins used in six approved biologics
• Prima RNApols^®, proprietary RNA polymerases for consistent, scalable, high-quality mRNA manufacturing (available in RUO- and GMP-grade)
• PeliCRM197^®, a validated carrier protein used in multiple approved vaccines (RUO and GMP) 

“This financing marks an important next step for Primrose and reflects confidence in our technologies, team and commercial opportunity,” said Andrew Burch, Chief Executive Officer of Primrose Bio. “As the engineering of biologic and nucleic acid medicines advances, developers need more robust production systems that also improve quality, yield, speed, scalability and cost. This capital will help us broaden adoption, enhance capabilities and accelerate customers moving therapeutic and vaccine programs forward toward clinical trials.” 

“Signet sees a compelling opportunity across Primrose’s portfolio,” said James Gale. “Having partnered with The Dow Chemical Company to establish Pfenex Inc. in 2009, we have seen the platform’s commercial value firsthand. Primrose is building on that foundation with further advances in Pfenex technology as well as Prima RNApols and PeliCRM197. We are pleased to invest in this next phase of growth and support the team as they scale the business and help more customers improve manufacturing performance across multiple therapeutic modalities.”

About Primrose Bio, Inc.

Primrose Bio develops and commercializes manufacturing technologies that close gaps in biologics, mRNA and vaccine production. Primrose’s major offerings include Pfenex Expression Technology^®: a proprietary microbial production system used in six approved products with up to 20x higher yields and a strong record across diverse protein modalities; Prima RNApols^®: improved enzymes for mRNA manufacturing; and PeliCRM197^®: a commercially validated CRM197 carrier protein used for conjugate vaccines.  Several of the world’s leading pharmaceutical companies use Primrose’s technologies in marketed products, including Merck, Jazz Pharmaceuticals, Alvogen, and Serum Institute of India. For more information, please visit: www.primrosebio.com.

About Signet Healthcare Partners

Signet Healthcare Partners is a healthcare growth equity firm that invests in commercial-stage pharmaceutical (pharma services and therapeutics) and medical technology companies. Founded in 1998 and based in New York, Signet has invested in more than 60 companies, supporting entrepreneurs with capital, strategic guidance, and deep industry networks. For more information, please visit: www.signethealthcarepartners.com.

SOURCE Primrose Bio

Left Lane Capital incubated and led the round as Rising Tide scales property management firms with shared technology and capital, without asking them to give up their name, team, or local relationships

CHICAGO, Sept. 22, 2026 — Rising Tide, which acquires and invests in independently owned residential property management companies, today announced the close of an undisclosed seed round led by Left Lane Capital. Left Lane incubated the company alongside CEO Blake Mohseni on a shared conviction: property management is a large and deeply fragmented market; it is mission-critical to the lives of everyday consumers, and its complexity across multiple stakeholders creates unique opportunities for AI to improve the customer experience.

Property management is a $100B+ market split across more than 240,000 property management firms that together handle a large share of residential rentals. Most run without the technology, systems, and back-office support that larger, well-capitalized platforms take for granted. The result: owners spend more time on manual admin than on building the tenant and owner relationships that actually differentiate a good property manager. Many also face a tough choice when it comes time to sell or transition: sell to a private equity firm that rebrands them under a national name, or figure out succession alone.

“AI is changing the definition of what premier service looks like in property management. It gives our operators more room for the relationships with owners and tenants that actually built their business,” said Blake Mohseni, Founder and CEO of Rising Tide. “This funding brings that same approach to more independent property management firms: real technology, real capital, and partnership instead of a takeover.”

Rising Tide takes a different approach: a federation of independent property management companies. Each one gets shared technology and capital to grow, while the local brand, the team, and the relationships an owner spent years building remain exactly as they are.

There’s no shortage of AI hype in property management right now. The hard part is knowing how to actually put it to work. That’s where Rising Tide comes in, through The Lab, where the company builds and tests its AI tools inside real property management businesses through hands-on implementation at no cost. The Lab is live today with three property management firms. Rising Tide keeps ownership of what it builds; the operators get full use of it for free, and their business data never leaves their hands.

Vinny Pujji, Co-founder and Managing Partner of Left Lane Capital, said, “We have invested over $100 million into AI companies transforming traditional services industries, from accounting to dental. Property management is universal, mission-critical, and not for the faint of heart. Blake and his team have the thoughtful approach needed to bring AI to the industry and drive modernization alongside tenured operators.”

About Rising Tide

Rising Tide is building a federation of independent property management companies with real capital and technology behind each one, while the local brand, team, and relationships are fully intact. Learn more at www.risingtidehq.com.

About Left Lane Capital

Founded in 2019, Left Lane Capital is a New York and London based venture capital and growth equity firm investing in high growth internet and consumer technology businesses globally. Left Lane’s mission is to partner with extraordinary entrepreneurs who create category defining companies across growth sectors of the economy. For more information, visit www.leftlane.com.

SOURCE Rising Tide